Industry Pulse
Research
New published research and supplier-side analysis of how research-grade peptide operations work.
Incretin Research Update: Retatrutide, CagriSema and Amylin Combinations Lead EASD 2026
EASD 2026 brought phase 3 retatrutide data, new CagriSema results, and an amylin plus tirzepatide combination. The field is moving beyond single-receptor agonism.
Read Analysis →
What the Peptide Sciences Shutdown Revealed: A Supplier-Side Analysis of Research Peptide Operations in 2026
What the Peptide Sciences Shutdown Revealed: A Supplier-Side Analysis of Research Peptide Operations in 2026Industry Pulse › What the Peptide Sciences Shutdown Revealed May 23, 2026 · Research In March 2026, Peptide Sciences voluntarily ceased operations. The company had been one of the largest U.S.…
Read Analysis →Research Use Only. Industry Pulse coverage is provided for research and educational reference only and does not constitute legal or medical advice. GENEVIUM products are not for human or animal consumption.